| Dr Eitan Sobel, MD | |
|
160 Allen St, Rutland, VT 05701-4560 | |
| (802) 775-7111 | |
| (573) 302-2241 |
| Full Name | Dr Eitan Sobel |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 160 Allen St, Rutland, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174519698 | NPI | - | NPPES |
| 1015594 | Medicaid | VT | |
| 01507533 | Medicaid | NY | |
| P00271468 | Other | MO | RAILROAD MEDICARE |
| 207478603 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2005018610 (Missouri) | Secondary |
| 207R00000X | Internal Medicine | 042-0011633 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Hospice | Norwich, VT | Hospice |
| Rutland Regional Medical Center | Rutland, VT | Hospital |
| Mountain View Center Genesis Healthcare | Rutland, VT | Nursing home |
| The Pines At Rutland Center For Nursing And Rehabi | Rutland, VT | Nursing home |
| Rutland Healthcare And Rehabilitation Center | Rutland, VT | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Health Centers Of The Rutland Region Inc | 2961467386 | 85 |
| Rutland Hospital Inc | 7214846377 | 157 |
News Archive
Inter Press Service reports on a research study conducted in Argentina that "explored women's knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies."
A study by researchers into the diagnosis of patients with lung cancer suggests that avoidable patient delays in reporting symptoms of the disease is an important factor in its treatment.
The Center For Public Integrity reports on the challenges Medicare faces in trying to ensure that prescription drugs paid for by its contracting health plans are actually prescribed by doctors. Meanwhile, The Miami Herald chronicles the latest chapter in the ongoing story about the state's pill mills.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
› Verified 2 days ago
| Entity Name | Rutland Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578527578 PECOS PAC ID: 7214846377 Enrollment ID: O20040427000707 |
News Archive
Inter Press Service reports on a research study conducted in Argentina that "explored women's knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies."
A study by researchers into the diagnosis of patients with lung cancer suggests that avoidable patient delays in reporting symptoms of the disease is an important factor in its treatment.
The Center For Public Integrity reports on the challenges Medicare faces in trying to ensure that prescription drugs paid for by its contracting health plans are actually prescribed by doctors. Meanwhile, The Miami Herald chronicles the latest chapter in the ongoing story about the state's pill mills.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
› Verified 2 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073567590 PECOS PAC ID: 2961467386 Enrollment ID: O20041129000784 |
News Archive
Inter Press Service reports on a research study conducted in Argentina that "explored women's knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies."
A study by researchers into the diagnosis of patients with lung cancer suggests that avoidable patient delays in reporting symptoms of the disease is an important factor in its treatment.
The Center For Public Integrity reports on the challenges Medicare faces in trying to ensure that prescription drugs paid for by its contracting health plans are actually prescribed by doctors. Meanwhile, The Miami Herald chronicles the latest chapter in the ongoing story about the state's pill mills.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
› Verified 2 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467681114 PECOS PAC ID: 2961467386 Enrollment ID: O20100804000784 |
News Archive
Inter Press Service reports on a research study conducted in Argentina that "explored women's knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies."
A study by researchers into the diagnosis of patients with lung cancer suggests that avoidable patient delays in reporting symptoms of the disease is an important factor in its treatment.
The Center For Public Integrity reports on the challenges Medicare faces in trying to ensure that prescription drugs paid for by its contracting health plans are actually prescribed by doctors. Meanwhile, The Miami Herald chronicles the latest chapter in the ongoing story about the state's pill mills.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
› Verified 2 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780969345 PECOS PAC ID: 2961467386 Enrollment ID: O20120321000420 |
News Archive
Inter Press Service reports on a research study conducted in Argentina that "explored women's knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies."
A study by researchers into the diagnosis of patients with lung cancer suggests that avoidable patient delays in reporting symptoms of the disease is an important factor in its treatment.
The Center For Public Integrity reports on the challenges Medicare faces in trying to ensure that prescription drugs paid for by its contracting health plans are actually prescribed by doctors. Meanwhile, The Miami Herald chronicles the latest chapter in the ongoing story about the state's pill mills.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eitan Sobel, MD 160 Allen St, Rutland, VT 05701-4560 Ph: () - | Dr Eitan Sobel, MD 160 Allen St, Rutland, VT 05701-4560 Ph: (802) 775-7111 |
News Archive
Inter Press Service reports on a research study conducted in Argentina that "explored women's knowledge and beliefs about cervical cancer, in the provinces with the highest mortality from this highly preventable form of cancer, to design more effective policies."
A study by researchers into the diagnosis of patients with lung cancer suggests that avoidable patient delays in reporting symptoms of the disease is an important factor in its treatment.
The Center For Public Integrity reports on the challenges Medicare faces in trying to ensure that prescription drugs paid for by its contracting health plans are actually prescribed by doctors. Meanwhile, The Miami Herald chronicles the latest chapter in the ongoing story about the state's pill mills.
LifeVantage Corporation, the maker of Protandim®, a clinically proven, science-based therapy for oxidative stress, announced today that a new peer-reviewed study involving Protandim® was published in the scientific journal PLoS ONE. The study, conducted by researchers at Louisiana State University, examined the biochemical mechanisms that underlie the ability of Protandim® to suppress tumors in mice. That ability was previously demonstrated by the authors in a study involving a mouse two-stage model of chemically-induced skin cancer.
› Verified 2 days ago
Michael William Gleeson, MD, PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Albert Cree Dr, Rutland, VT 05701 Phone: 802-786-1400 Fax: 802-786-1405 | |
Sudhir Babu Movva, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-747-1633 Fax: 802-775-7214 | |
T Ray Lovko, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 Stratton Rd, Rutland, VT 05701 Phone: 802-773-3386 Fax: 802-773-4578 | |
Dr. Louis Block Meyers, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 Fax: 802-772-2556 | |
William Orourke, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 69 Allen St, Suite 11, Rutland, VT 05701 Phone: 802-775-0033 | |
Mark C Stickney, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Commons St, Rutland, VT 05701 Phone: 802-773-7155 Fax: 802-773-7616 | |
Dr. Mark Edward Logan, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 199 Stratton Rd, Rutland, VT 05701 Phone: 802-775-7798 |